HTEC — ROBO Global® Healthcare Technology and Innovation ETF
Data updated: 2026-08-27
HTEC — ROBO Global® Healthcare Technology and Innovation ETF. Holdings, fees, performance and SEC filings.
HTEC Fund Overview
HTEC — ROBO Global® Healthcare Technology and Innovation ETF is a US ETF managed by Exchange Traded Concepts Trust, categorised as United States Multi-Cap / All-Cap Growth Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Exchange Traded Concepts Trust
- Category: United States Multi-Cap / All-Cap Growth Health Care Equity
- Assets under management: $53.34M
- 1-year return: 24.4%
- Ticker: HTEC
- SEC CIK: 0001452937
- SEC series ID: S000065730
- Share class ID: C000212575
HTEC Holdings
Top 10 holdings of ROBO Global® Healthcare Technology and Innovation ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| AxoGen, Inc. | 3.16% |
| Arrowhead Pharmaceuticals, Inc. | 2.56% |
| Twist Bioscience Corp | 2.34% |
| Glaukos Corporation | 2.22% |
| Natera, Inc. | 2.17% |
| Tempus Ai, Inc. | 2.13% |
| Novocure Limited | 2.04% |
| Alnylam Pharmaceuticals, Inc. | 2.01% |
| Guardant Health, Inc. | 1.99% |
| Thermo Fisher Scientific Incorporated | 1.99% |
HTEC Portfolio Allocation
Asset-class allocation of ROBO Global® Healthcare Technology and Innovation ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 0.3% |
HTEC Performance
Total returns for HTEC (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -1.9% |
| 1 year | 24.4% |
| 3 years (annualised) | 3.6% |
| 5 years (annualised) | -6.2% |
HTEC Risk Information
Risk metrics for HTEC, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 17.6%
HTEC Costs and Fees
HTEC costs about $68 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.68%
- Gross expense ratio: 0.80%
- Portfolio turnover: 38%
- Brokerage commissions: 1.79 bps of average net assets (SEC N-CEN)
HTEC Cashflows
Over the 12 months to 2026-04, ROBO Global® Healthcare Technology and Innovation ETF had net inflows of $3.53M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | $0 |
| 2026-03 | $0 |
| 2026-02 | $3.27M |
| 2026-01 | $0 |
| 2025-12 | $0 |
| 2025-11 | $0 |
HTEC Debt Constituents
No individual debt constituents are reported in ROBO Global® Healthcare Technology and Innovation ETF's latest SEC N-PORT filing.
HTEC Prospectus and SEC Filings
Official ROBO Global® Healthcare Technology and Innovation ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-08-27
- Prospectus (485BPOS) — filed 2025-08-26
- Prospectus supplement (497) — filed 2024-09-03
- Portfolio holdings (N-PORT) — filed 2026-06-26
- Portfolio holdings (N-PORT) — filed 2026-03-31
- Portfolio holdings (N-PORT) — filed 2025-12-29
- Annual census (N-CEN) — filed 2026-07-07
- Annual census (N-CEN) — filed 2025-07-14
Related Funds
Other United States Multi-Cap / All-Cap Growth Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.